Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Nordic Science Investments (NSI) is a venture capital organization founded in Helsinki, Finland. Established to partner with founders, NSI focuses on transforming scientific discoveries into successful startups. The firm emphasizes early-stage investments, particularly in university spinouts, and aims to generate both profit and societal impact. NSI's commitment to supporting startups that tackle global challenges is evident in its investment strategy.
Currently, NSI manages a portfolio of 20 companies and operates primarily in Europe, particularly within the Nordics. The firm has a strong connection to Finnish research universities, including Aalto University and the University of Helsinki, which enhances its ability to identify and support promising scientific innovations. NSI's approach combines financial backing with strategic guidance, ensuring that portfolio companies have access to the necessary resources for commercialization.
As of now, NSI has not publicly disclosed its total assets under management (AUM) or specific fund sizes. However, the firm is known for its active involvement in the early-stage funding landscape, particularly in sectors that drive significant advancements in science and technology.
Nordic Science Investments specializes in sectors such as deeptech, healthtech, and life sciences. The firm invests across various stages, including pre-seed, seed, Series A, and Series B funding rounds. Investment amounts typically range from €50,000 to €3.5 million, allowing NSI to support a diverse array of startups. The organization particularly seeks to invest in companies rooted in scientific research, emphasizing the importance of innovation that addresses pressing global challenges.
NSI's investment strategy is designed to bridge the gap between academia and business, focusing on university spinouts that have the potential to create meaningful advancements. The firm looks for founders who are deeply knowledgeable in their fields and possess a clear vision for their startups. Additionally, NSI values collaboration and often encourages partnerships between its portfolio companies and academic institutions to enhance research and development efforts.
Nordic Science Investments has built a diverse portfolio of 20 companies, each addressing significant challenges through innovative solutions. Notable portfolio companies include:
This portfolio reflects NSI's commitment to investing in companies that leverage scientific advancements to create impactful solutions across various sectors.
Dr. Alexandra Gylfe, PhD - Founding Partner. Dr. Gylfe has a strong background in scientific research and venture capital, having led multiple investments in the healthtech sector.
Mr. Matti Hautsalo - Founding Partner. Mr. Hautsalo brings extensive experience in technology commercialization and has a track record of successful investments in deeptech.
Mr. Jari Strandman - Founding Partner. Mr. Strandman specializes in life sciences and has been instrumental in supporting university spinouts.
Mr. Anssi Uimonen - Founding Partner. Mr. Uimonen has a background in engineering and has led investments in various scientific fields.
Mr. Gerard de Bourbon - Venture Partner. Mr. de Bourbon has experience in international business development and strategic partnerships.
Ms. Hanna Hämäläinen - Analyst. Ms. Hämäläinen supports the investment team with market research and analysis of potential portfolio companies.
Mr. Mart Maasik - Partner. Mr. Maasik focuses on operational support for portfolio companies, ensuring they have the resources needed for growth.
To pitch Nordic Science Investments, founders should utilize the preferred channel of their website or email. A well-structured pitch deck should include an overview of the business model, market analysis, and scientific foundation of the startup. NSI appreciates clarity and conciseness in presentations.
There are no specific application forms or portals mentioned, but founders can expect a response within a reasonable timeframe after submission. Warm introductions are beneficial but not mandatory.
As of March 2023, Nordic Science Investments has continued to expand its portfolio, actively investing in startups that leverage scientific advancements. The firm has made several notable investments in healthtech and deeptech sectors, reflecting its commitment to supporting innovation that addresses global challenges.
Recent activities include investments in companies such as **AiAtella**, which automates cardiovascular diagnostics using AI, and **PrecisionPhage**, which utilizes phage technology to combat antibiotic resistance. These investments align with NSI's focus on scientific innovation and societal impact.
What are Nordic Science Investments' investment criteria?
NSI primarily invests in early-stage science-based startups, particularly those that are university spinouts. The firm focuses on sectors such as deeptech, healthtech, and life sciences, with investment amounts ranging from €50,000 to €3.5 million.
How can startups apply or pitch to Nordic Science Investments?
Startups can pitch to NSI through their website at nordscience.fi or by emailing info@nordscience.com. It is recommended to provide a clear overview of the business model, market potential, and scientific basis of the startup.
What makes Nordic Science Investments different from other VCs?
NSI distinguishes itself by its strong connections with Finnish research universities and its focus on transforming scientific discoveries into successful startups. The firm emphasizes collaboration between academia and industry, which enhances the commercialization process.
What is the geographic scope of Nordic Science Investments?
NSI primarily invests in Europe, with a particular focus on the Nordics. The firm seeks to support startups that are addressing global challenges through scientific innovation.
What is Nordic Science Investments' post-investment involvement like?
NSI actively engages with its portfolio companies, providing strategic guidance and leveraging its network to facilitate collaboration with academic institutions. This support is aimed at enhancing the startups' growth and commercialization efforts.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.